Molecular principle of the cyclin-dependent kinase selectivity of 4-(thiazol-5-yl)-2-(phenylamino) pyrimidine-5-carbonitrile derivatives revealed by molecular modeling studies
Author:
Affiliation:
1. Institute of Functional Nano and Soft Materials (FUNSOM)
2. Soochow University
3. Suzhou
4. P. R. China
5. College of Pharmaceutical Sciences
6. Zhejiang University
7. Hangzhou
Abstract
Due to the high sequence identity of the binding pockets of cyclin-dependent kinases (CDKs), designing highly selective inhibitors towards a specific CDK member remains a big challenge.
Publisher
Royal Society of Chemistry (RSC)
Subject
Physical and Theoretical Chemistry,General Physics and Astronomy
Link
http://pubs.rsc.org/en/content/articlepdf/2016/CP/C5CP05622E
Reference70 articles.
1. A family of human cdc2-related protein kinases.
2. Complexities in the development of cyclin-dependent kinase inhibitor drugs
3. Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
4. Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery novel VEGFA inhibitors through structure-based virtual screening and verify the ability to inhibit the proliferation, invasion and migration of gastric cancer;Journal of Saudi Chemical Society;2023-07
2. Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations;International Journal of Molecular Sciences;2023-01-31
3. Evaluating the ability of end-point methods to predict the binding affinity tendency of protein kinase inhibitors;RSC Advances;2023
4. Computational modeling studies reveal the origin of the binding preference of 3‐(3,4‐di hydroisoquinolin‐2( 1H )‐ylsulfonyl)benzoic acids for AKR1C3 over its isoforms;Protein Science;2022-11-22
5. Predicting the mutation effects of protein–ligand interactions via end-point binding free energy calculations: strategies and analyses;Journal of Cheminformatics;2022-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3